Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Sep 7, 2026

Revenue (TTM)
$145.68B
+26.2% YoY
Gross margin
13.7%
EPS (latest q)
$7.61
vs $6.22 est · beat
52-wk position
96.8%
-1.9% vs 52w high · +4.3% 1mo

Price (last ~year)

Humana Inc. (HUM) is trading at $401.54, near its 52-week high, even as Cantor Fitzgerald maintains a neutral rating citing contract management challenges and recent downward revisions to earnings estimates. The company reported $40.87 billion in revenue for the quarter ended June 30, 2026, contributing to $145.68 billion in trailing twelve-month revenue and a streak of four consecutive quarterly earnings beats. Institutional activity in the second quarter showed mixed sentiment, with new positions established by firms like Nykredit A S offset by stake reductions from investors such as Van ECK Associates Corp.

Valuation

Market cap
$48.22B
P/E
38.02
PEG
1.361
P/B
2.541
P/S
0.331
Beta
0.745
Analyst target
$418.61

Quality & returns

Gross margin
13.7%
Operating margin
3.5%
Profit margin
0.9%
ROE
6.9%
ROA
3.9%

Price movement

Last
$401.54
1-month
+4.3%
3-month
+10.4%
RSI (14)
64
vs SMA200
+44.1%
52-wk position
96.8% -1.9% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$40.87B$1.36B$693.0M$1.31B
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots